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Background
Crohn’s Disease (CD) is a chronic inflammatory bowel dis-
ease characterised by recurrent intestinal inflammation [1].
Adipose tissue has metabolic and immune functions regu-
lated through the expression of hormones and cytokines
[2,3]. Conventionally, adiposity in CD is believed to reflect
disease activity, nutritional status and possibly corticoster-
oids. Emerging data suggests that adipose tissue may play
a more complex immunoregulatory role in CD [4].
Methods
CD patients attending the gastroenterology department
were recruited over a 4 week period were invited to par-
take in this pilot study. The following data was collected:
Extent of disease and previous treatments, current disease
activity and biometric measurements of adiposity (Body
mass index (BMI), waist hip ratio, mid upper arm circum-
ference, skin fold thickness and percentage body fat using
biometric impedance analysis (BIA)).
Results
27 patients were recruited in this pilot study. 16 (59%) had
BMI >25 and (classified as overweight or obese), 10 had
normal BMI and 1 had BMI <18. 32% had body fat stores
above normal, 44% within normal range and 24% had low
fat stores as measured with BIA. Numbers were too small
in this pilot study to establish a relationship between dis-
ease pattern and/or activity, those requiring >1 course of
steroids in the previous year and those on anti-TNF ther-
apy were more likely to have normal range BMI than the
group as a whole. Self reported abdominal pain and
decreased well being was highest in patients with an
increased BMI.
Conclusions
Obesity rates in the general population are rising [5]. Our
study indicates that obesity does present in the CD popu-
lation. Adipose tissue may be a source of proinflammatory
cytokines thus altering the natural history of CD in these
patients [6]. Even if there is no impact on disease progres-
sion, our findings have important implications for current
CD drug and nutritional management.
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